ConocoPhillips R&D remained flat by 0.0% to $19.50M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 3.7%, from $20.25M to $19.50M. Over 4 years (FY 2021 to FY 2025), R&D shows an upward trend with a 5.9% CAGR.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ4 2025Feb 17, 2026
How to read this metric
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Detailed definition
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Peer comparison
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
Metric ID:
research_and_developmentHistorical Data
5 years
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $62.00M | $71.00M | $81.00M | $81.00M | $78.00M |
| YoY Change | — | +14.5% | +14.1% | +0.0% | -3.7% |
Range$62.00M – $81.00M
CAGR+5.9%
Avg YoY Growth+6.2%
Median YoY Growth+7.0%
R&D at Other Companies
Frequently Asked Questions
- What is ConocoPhillips's r&d?
- ConocoPhillips (COP) reported r&d of $19.50M in Q4 2025.
- How has ConocoPhillips's r&d changed year-over-year?
- ConocoPhillips's r&d decreased by 3.7% year-over-year, from $20.25M to $19.50M.
- What is the long-term trend for ConocoPhillips's r&d?
- Over 4 years (2021 to 2025), ConocoPhillips's r&d has grown at a 5.9% compound annual growth rate (CAGR), from $62.00M to $78.00M.
- What does r&d mean?
- The money spent on creating new products or improving existing ones to drive future growth.